Company Filing History:
1 out of 4 
1 out of 2 
1 out of 5,072 
Years Active: 2022
Title: Catherine Mullie-Demailly: Innovator in Malaria Treatment
Introduction
Catherine Mullie-Demailly is a notable inventor based in Cagny, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating malaria. Her innovative work has garnered attention in the scientific community.
Latest Patents
Catherine holds a patent for aminopyridinemethanol compounds and their use. The present invention is directed to novel compounds of Formula (I), including pharmaceutically acceptable salts or solvates thereof. These compounds are particularly useful in the treatment or prevention of malaria, showcasing her commitment to addressing critical health issues.
Career Highlights
Throughout her career, Catherine has worked with esteemed institutions such as Université Amiens Picardie Jules Verne and Centre Hospitalier Universitaire d'Amiens. Her experience in these organizations has allowed her to collaborate with other professionals and contribute to important research initiatives.
Collaborations
Catherine has collaborated with notable colleagues, including Pascal Sonnet and Alexandra Dassonville-Klimpt. These partnerships have enriched her research and expanded the impact of her inventions.
Conclusion
Catherine Mullie-Demailly is a pioneering inventor whose work in developing malaria treatment compounds highlights her dedication to improving global health. Her contributions to the field are invaluable and continue to inspire future innovations.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.